Loading…
Loading…
Brookfield Real Assets Income Fund Inc. is a closed ended fixed income mutual fund launched and managed by Brookfield Investment Management Inc. The fund is co-managed by Schroder Investment Management North America Inc. It invests in fixed income markets of the United States. The fund primarily invests in securities and other instruments of companies, which includes real estate securities, infrastructure securities, and natural resources securities. Brookfield Real Assets Income Fund Inc. was formed on December 2, 2016 and is domiciled in the United States.
Is RA's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Brookfield Real Assets Income Fund Inc. (NYSE: RA - Get Free Report) was the target of a large decrease in short interest in August. As of August 14th, there was short interest totaling 56,549 shares, a decrease of 36.8% from the July 30th total of 89,421 shares. Based on an average daily trading volume, of 144,278
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LAPIX Therapeutics has appointed Abbas Kazimi, Chief Executive Officer of Nimbus Therapeutics, to its Board of Directors as the Company advances its TIM 3/4 agonist program through Phase 1b clinical trials in rheumatoid arthritis (RA) and atopic dermatitis (AD). Kazimi brings more than two decades of biotechnology leadership experience spanning company building, corporate strategy, financing, and drug development. As CEO of Nimbus Therapeutics, he has overseen.
Brookfield Real Assets Income Fund is a fixed income CEF, not a direct real assets holder, despite its name. RA primarily invests in corporate and securitized credit, with only 7.9% in equities and no direct commodity or real estate exposure. The fund's 10% distribution is supported by significant return of capital (~30%), with true cash flow yield closer to 7%.
Brookfield Real Assets Income Fund Inc. (NYSE: RA - Get Free Report)'s share price crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $12.93 and traded as high as $12.97. Brookfield Real Assets Income Fund shares last traded at $12.9540, with a volume of 122,956 shares
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata